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Abstract: The new emerging coronavirus SARS-CoV2 is an alerting pandemic worldwide. 
Understanding the epidemiology, viral behavior in the host, and the severity of the disease 
in an infected patient is a demanding approach for the healthcare system which lead to 
plan and contemplate the response for further waves of the same virus and even other 
related viruses. The evaluation of the protection measurements along with analyzing the 
recorded data of epidemiology and spread provides thorough insights toward the new 
Coronavirus modes of transmission, infection, and severity. Kurdistan Region of Iraq was 
hit by the SARS-CoV2 on March 2020 when first confirmed case recorded. The present 
paper analyzed a full month data of confirmed hospitalized and quarantined cases with 
regard to age, sex, geographical distribution. The highest risks were shown to be males of 
their young ages of 30-39 years old in Sulaimani province due to the social structure of the 
Kurdish population and the geographical position of Sulaimani. Social integration played 
a significant role in the spreading the virus in all cities of Kurdistan first onset of the virus 
in the community. Diagnosed hospitalized cases were mostly suffered from high fever, dry 
cough and breathing difficulties. The mortality rate was shown to be reasonable, and the 
majority of the cases were recovered after hospitalization and receive supportive treatment. 
Social distancing and total lockdown played a significant role in viral spread containment. 
The health authorities prevented devastating outbreak through tracing all the cases and 
their contacts, isolating the suspicious contacts, quarantining the neighborhoods were the 
virus found. Further investigation is needed in a larger scale of data in order to be armed 
with adequate knowledge for any other waves of COVID-19 in the region. 
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Coronaviruses cause contagious respiratory infections in humans. Pneumonia and progressive 
respiratory failure are common symptoms of the new coronavirus outbreak (REF). A sever 
public health threat emerged during the previous Coronaviruses infections including severe 
acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) in 
many countries (Graham et al., 2013). In late December 2019, a series of pneumonia cases 
were admitted to the hospitals with clinical presentations much resembling viral pneumonia. 
These patients were epidemiologically linked to seafood and wet animal wholesale market in 
Wuhan, Hubei Province, China (Bogoch et al., 2020).  
Detailed sequencing analysis of samples from the lower respiratory tract of the symptomatic 
patients indicated a novel Coronavirus, which was named the 2019 novel Coronavirus (2019-
nCoV) and later was publicized by WHO on February 11th, 2020 as COVID-19) causing 
severe acute respiratory syndrome disease (SARS-CoV2) (Sohrabi et al., 2020:Zhou et al., 
2020). The origin of SARS-COV2 is from an animal source especially wild bats and 
pangolins (Figure 1), because the genetic sequencing of this virus is significantly similar to 
those detected in these animals (Cagliani et al., 2020). 
The etiological agent of the new disease is a member of the Coronavirus family that includes 
at least six other types of human infectious Coronaviruses, such as (SARS-CoV) and (MERS-
CoV) (Zhang et al., 2020). Coronavirus is a genus of Coronaviridae family, which are 
enveloped and contain a large positive-sense single-stranded RNA genome. The genomic 
RNA is 27–32 kb in size, capped and polyadenylated. Three serologically distinct groups of 
Coronaviruses have been described. Within each group, viruses are characterized by their 
host range and genome sequence (Cui et al., 2019). Coronaviruses have been identified in 
mice, rats, chickens, turkeys, swine, dogs, cats, rabbits, horses, cattle and humans, which can 
cause a variety of severe diseases including gastroenteritis and respiratory tract diseases (van 
der Hoek et al., 2004). 
The new coronavirus outbreak originated from Wuhan city, Hubei province, China late last 
year, and it was the start of the fast-spreading novel infection around the world (Ayittey et 
al., 2020). The spread of the new virus caused an elevated mortality rate worldwide 
compared with the mortality rates of common conditions such as seasonal flu (Meo et al., 
2020; Koh et al., 2015).  
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Figure 1 The Role of Animals in the Evolution and Transmission of the Coronavirus 
The evolutionary history of SARS-CoV2 was shown by applying the Maximum Likelihood 
(ML) program based on the Tamura-Nei model. The bootstrap value made up of 1000 
replicates is taken to be the evolutionary history of the taxa analyzed (Figure 2). Tree 
branches corresponding to partitions copied in less than 50% bootstrap reproduces are 
collapsed. The analysis involved 56 nucleotide sequences. Evolutionary analyses were 
conducted in MEGA7. 
Furthermore, Muscle alignment tool was used to display the nucleotide variation between 
SARS-CoV-2 sequences. Stars on the top of the sequences and colour represent the 
conserved nucleotides among the sequences. Non-colour nucleotides between the sequences 
showed the nucleic acid variations (Kumar et al., 2016). 
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Figure 2 Diagonal Plots to Graphically Compare Biological Sequences and Identify Regions 
of Close Similarity. 
 
A newly emerging infectious disease such as this virus contributes to a severe public health 
risk. The unprecedented rate of death has been recorded daily first in China, then Iran and 
Italy early this year (Raoofi et al., 2020). The fast spread of COVID-19 in the world causes 
different ranges of illnesses and deaths. The dramatically increase of positive cases of the 
new virus has driven many countries around the world to go through lockdown processes and 
social distancing. Therefore, the world governments have taken a severe step to fight against 
this new disease (Sjödin et al., 2020). In most countries' lockdown measures have been taken, 
to contain the spread of the novel Coronavirus. This includes lockdown of schools, 
universities, public transports, airlines, small and large companies and businesses (Gudi and 
Tiwari, 2020).  
Here, in Kurdistan region of Iraq with around five million in population, at the beginning of 
the COVID-2019 outbreak, the Kurdistan regional government (abbreviated KRG) 
quarantined those travelers who came back for 14 to 30 days. Then the government closed the 
schools, universities, religious locations, markets and public areas for preventing the spread 
of the new disease. Transport systems between cities are postponed or cancelled. As a result, 
the first case of the virus was detected during March, which is much later than many western 
countries.  
The patients who were first infected with COVID-19 experienced symptoms such as fever, 
cough and fatigue. Nasal congestion, sore throat, runny nose, and diarrhoea have also been 
detected in some cases. However, most of the cases in the Kurdistan Region have been mild 
cases with little to no symptoms, with most recovering without taking any particular medicine 
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which accounts to 80% of the cases whereas almost 20% of the patients have suffered severe 
symptoms. (Ai et al., 2020; Jiang et al., 2020). 
This study aims to describe the epidemiological distribution, clinical characteristics, 
treatment, and outcomes of patients confirmed to have the 2019-nCoV infection in Iraqi 
Kurdistan region and to compare the clinical features of the diagnostic patients with other 
countries who have been infected with this disease. The study findings will inform the global 
community of the emergence of this novel Coronavirus and its clinical features. 
 
2. METHODS 
Study Design and Data Collection  
All 214 patients with COVID-19 positive test results confirmed from the hospitals of the 
Kurdistan region from March 1st to April 4thwere questioned in this study. Written or oral 
informed consent was obtained from the patients. A standard questionnaire was adopted to 
gather information on sociodemographic and clinical characteristics.  
Questionnaire and Data Analysis 
The following information was taken from each patient, and the questionnaire was divided 
into two different parts. The first part included demographic data of the patients (sex, age, and 
work experience), whereas the second part of the questionnaire, included the knowledge 
patients had on how the virus was transmitted from one person to another. Besides, the 
gathered data contained the medical history of the patients under the study. Statistical 
analysis of all data was performed with GraphPad Prism (version 8.0.1.244, GraphPad 
Software, La Jolla, CA, USA). 
Assemble and Align Nucleotide Databases 
For the showing and finding evolutionary relationships among SARS-COV-2 sequences in 
distinct countries, molecular phylogenetic dendrogram will be generated. Firstly, because the 
Iranian sequences of SARS-CoV2were available on the genomic sequences of National 
Center for Biotechnology Information (NCBI), the sequence was used as Blast query 
sequences to search for the original dataset. All sequences (≥ 50%) of sequence identity, were 
collected and downloaded. Analysis of each of the Multiple Sequence Alignment (MSA) and 
phylogenetic tree was taken using molecular evolutionary genetic analysis, version 7 
(MEGA7) software (Kumar et al., 2016). The MSA was built and aligned using muscle tool, 





3. RESULTS AND DISCUSSION 
Impact of Age on Coronavirus Infection 
A new infectious disease, caused by severe acute respiratory syndrome Coronavirus 2 
(SARS-CoV2), was detected in Wuhan, China, in December 2019. The COVID-19 spread 
rapidly, reaching epidemic proportions in China. The disease was detected in 189 other 
countries. As of April 9, 2020, over 1,536,094 cases of COVID-19 were reported, with > 
89,877 deaths. No specific therapeutics is available, and current management includes travel 
restrictions, patient isolation, and supportive medical care. The results of this study revealed 
that two age groups range from (30-39) and (40-49) years were infected (Figure 3), in 
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contrast, to the recorded data from other countries, in which older age (≥65 years) were 
associated with higher severity and mortality in patients with COVID-19 (Onder et al., 
2020).The percentages of older age were much higher in the deceased group than in the 
survived group of patients with COVID-19, especially in the Italian population. This may be 
due to the demographic characteristics of the Italian population that differ from other 
countries. In 2019, approximately 23% of the Italian population was aged 65years or older. 
Ultimately, COVID-19 is more serious in older patients, so the older age distribution in Italy 
may explain, in part, Italy's higher case-fatality rate compared with that of other countries 
(Tuite et al., 2020: Yang et al., 2020).  
 
 
Figure 3 The COVID-19 Patients' Age-specific Infection rate in the Iraqi Kurdistan Region 
During March 2020. 
 
Gender and its Relation to COVID-19 
The gender factor was also observed in COVID-19 patients. The obtained data analysis 
showed that men had a significantly higher susceptibility rate than women. Despite a similar 
proportion of male and female patients of COVID-19, the incidence of the disease in male 
was higher than females which agreed with (Jin et al., 2020) (Figure 4). Although, for the 
available data of some of the countries, there is not any clear pattern in terms of whether 
women or men are more likely to be diagnosed with COVID-19. In some of these countries, 
there is a higher proportion of confirmed cases among women (over 50%), and in some other 
countries, it is higher among men (Wei et al., 2020). Iran is one of the most epidemic 
countries for COVID-19, and there is no information regarding the proportion infection rate 
between male and female to this infectious disease (Jinet et al., 2020; Rahimzadeh et al., 
2020).  
Older ages and male gender are risk factors for the worst outcome in patients with COVID-
19. Because the severity and mortality of COVID-19 do not depend on age susceptibility 
(Rahimzadeh et al., 2020: Wu and Mc Googan, 2020), it is habitual to think women are less 
likely to be affected by many infectious bacteria and viruses than men, partly because of their 
more robust innate and adaptive immune responses (REF). However, this may be related to 
the occupational risk factors for men in exposure to the virus. They may be more prone to 
have higher severity and mortality independent of age and susceptibility. Thus, the new 
disease could be seen that the elderly male patients with certain chronic diseases were a more 
challenge to treat, resulting in an extended hospital stay and slow recovery. 
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Figure 4 The Gender Proportional Rate within COVID-19 Infected Patient during March 
2020. 
 
Geographical Distribution of Coronavirus in Kurdistan of Iraq  
Global epidemic curves reflect that COVID-19 rapidly spread from a single city to the entire 
country in just a few days. In parallel, the collected data revealed that within 214 positive 
cases 105, 66, 14 and 29 patients from Sulaimani, Erbil, Duhok and Halabja cities, 
respectively, were estimated with COVID-19 (Figure 5). The highest incidence from 
Sulaimani may be due to the geographical expansion with the border of Iran because the 
economic activity in this area is bustling. Travelling of the residents was at a high rate during 
the crisis in comparison with other cities through the border.  
 
 
Figure 5 Distribution of COVID-19 in Iraqi Kurdistan Region Cities during March 2020. 
 
Number of Infected Peoples by Coronavirus and their Occupation 
Although the KRG focused on the controlling of public health outbreak tactics like isolation, 
quarantine, social distancing, and community containment, the diagnosed cases of COVID-19 
were immediately isolated. Nevertheless, in March, the number of cases increased in the 
region. The collected data showed that the most diagnosed cases in all cities of Iraqi 
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countries where COVID-19 was epidemic (Figure 6A). The other 130 cases were from 
residents who have had contacts with the returnees or secondary contact to those who 
contacted them. This is maybe due to the fact of using public transport, airplanes, crowd 
rides, and close contact during travel. Nevertheless, most of the returnees have also contact 
with their families and relatives before being tested for the virus. The government later 
warned all the returnees to reach out testing centers to confirm clarity of the virus in their 
bodies. Freely moving carriers caused a dramatic increase in cases due to their contact 
(Figure 6B). This is related to the context of the social structure of the Kurdish people and 
social relations. It has been indicated from the tracking and tracing data that the source of 
infection in the Kurdistan Region of Iraq was from patients or carriers that have returned 






Figure 6 A) Route of Infection within an Infected Person with COVID-19. B) Occupation of 
the Infected Person with COVID-19. The Blue Dots Represent the Number of Cases. 
Signs and Symptoms of Infected Peoples by SARS-CoV2 
The signs and symptoms of COVID-19 were ranged from a mild fever and fatigue to the most 
severe difficulty of breath. Death also occurred due to the severity of the disease in some 
cases. According to the data, the most common symptoms documented in almost 79% of the 
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fever,fatigue, the difficulty of breathing were also recorded frequently. The same signs and 
symptoms wereobserved in all patheints in all of the world (Huang et al., 2020). In COVID-
19 patients, fever, cough and myalgia were the most common symptoms, followed by chest 
distress and shortness of breath. However, upper respiratory tract symptoms (e.g. nasal 
congestion, nasal discharge and sore throat) and gastrointestinal symptoms (e.g. abdominal 
pain and diarrhoea) were relatively rare (Huang et al., 2020). It is noteworthy that if the fever 
was used to trigger screening/testing for COVID-19, a substantial number of patients without 






Figure 7 Signs and Symptoms of Infected Peoples by SARS-CoV2 (A) and their Condition 
(B). 
 
Prevalence of COVID-19 Infection 
The symptoms which were started from (10-14) days, as mentioned in other studies (Huang 
et al., 2020) either mild, severe or critical, which lead to death. Fortunately, in Iraqi Kurdistan 
region Most cases were classified as mild (84.11%). However, 14.49% were severe, and 
1.40% were critical (i.e., respiratory failure, septic shock, and/or multiple organ dysfunction 
or failure). The death cases were rare in compared with other places which suffer from 
infection (De Natale et al., 2020: Lauer et al., 2020) (Figure 8A). The efforts of symptom 
relief and total treatment of the virus is an ongoing challenge; however, to date, there is no 
robust data suggests any specific treatment for COVID-19 (Onder et al., 2020). Medications 
used mostly for the alleviation of symptoms and not an eradication of the virus. Additionally, 
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In the Kurdistan Region of Iraq, this approach was supported by oxygenation, fluid 
management, and mechanical ventilation as needed. 
March 2020 considered being the challenge for the Kurdistan Region Government and health 
sector. This isbecause the first officially confirmed case were at the beginning of that month. 
The government obliged to issue a sequence of emergency orders to restrain the outbreak. 
The cases of COVID-19 infection was increasing per days (Figure 8B). However, the 
dramatic increase was recorded in the middle of March in all cities, especially in Sulemani. In 
Hawler the records of cases reached its peak on March 22th and the others at the beginning of 
April 2020. This has been declined with the actions taken by the local governments, including 
total lockdown of cities as well as more understandings and new information has been 
released throughout media and published articles. Social distancing played an important role 
in decreasing the record numbers of new cases. This included the prohibition of all social 
activities, crowds, and social events. Virtually all transportation was subsequently restricted 
at a national level. People who had been in contact with COVID-19 cases were quarantined in 
individual quarantine facilities, where they could be monitored for onset of symptoms. 
Fortunately, recovery from the disease were seen in most of the cases, although no specific 
treatment was available (Figure 8). Supportive treatment and medical care, along with a 
healthy diet, might be crucial for recovery (Gudi and Tiwari, 2020). Globally, the death rate 
was recorded to be 2.3 % (Lai et al., 2020). However, as indicated in the present data and 
others, the mortality rate was higher in older adults, specifically those with underlying 
diseases. These patients are among those who suffered severe symptoms patients with mild 
symptoms or asymptomatic were less prone to death. These preexisting comorbid conditions 
included cardiovascular disease, diabetes, chronic respiratory illnesses, hypertension and 
malignancy. In the present study, among the 214 positive cases, 3 deaths were recorded, all of 
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Figure 8: Prevalence of COVID-19 Infection Per Days of the Month in different Cities (A) 
and their Situation (B). 
 
4. CONCLUSION 
In conclusion, the status of COVID-19 in the Kurdistan region for the first month of onset is 
well controlled. This is remarkably related to the immediate response of the authorities to the 
global alerts, application of extreme protection measurement and protocols of lockdown and 
social distancing, the containment of the viral spread which eventually weakened the virus 
mutation in the population. However, the future direction should be well designed to respond 
to any second waves of the viral spread, especially with the relaxation of the protective 
measures and reopening the market places were crowd are usually gathered. Further research 
is mandatory to understand the community behaviors and the viral mutation and 
aggressiveness in order to be well prepared for any other viral attacks. 
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